Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Search Product Recalls

Try:····

Filters

Category

All Categories Food Medication Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Severity

All Severities Class I (High Risk)Class II (Moderate)Class III (Low)

Source

All Sources FDA CPSC USDA NHTSA

Status

Include terminated recalls

Clear all filters

Showing 1961–1980 of 14370 results

Sort:

Newest first Oldest first

Clopidogrel Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

BusPIRone Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Simvastatin Tablets (Accord) - Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

rOPINIRole Tablets 2 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Daptomycin Injection 350 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Aripiprazole Tablets 15 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Atorvastatin Calcium Tablets 80 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Finasteride Tablets 1mg (Accord Healthcare) – CGMP Issues (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Pravastatin Sodium Tablets 40 mg (Accord Healthcare) – Manufacturing Deviation (2023)

CGMP Deviations: recalling drug products following an FDA inspection.

Class IIModerate

FDAFeb 7, 2023Nationwide• Accord Healthcare, Inc.

Levothyroxine Sodium Tablets 112 mcg (Alvogen) – Sub-Potent Drug (2023)

Sub-Potent Drug: Out of specification for assay at the 24 month interval.

Class IIModerate

FDAFeb 6, 2023Nationwide• Alvogen, Inc

Abelcet Injection 5 mg/mL (Leadiant Biosciences) – Sterility Concern (2023)

Lack of assurance of sterility: Medial fill with presence of Cupriavidus pauculus.

Class IIModerate

FDAFeb 3, 2023Nationwide• Leadiant Biosciences, Inc.

Dermoplast Antibacterial Spray (Advantice Health) – Subpotent Drug (2023)

Subpotent Drug: Low assay observed in one of the two active ingredients during stability testing.

FDAFeb 2, 2023Nationwide• Advantice Health, Llc

Posaconazole Tablets (Biocon Pharma) – High Impurities (2023)

Failed Impurities/Degradation Specifications: High Out Of Specification degradation results.

Class IIModerate

FDAJan 31, 2023Nationwide• BIOCON PHARMA INC

Atropine Sulfate Eye Solution (Akorn) – Failed Stability (2023)

Failed Stability Specifications: Out of specification test results for viscosity was identified at the 12M stability timepoint.

FDAJan 30, 2023Nationwide• Akorn, Inc.

TIROSINT-SOL Levothyroxine Solution 175mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 137mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 37.5mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 112mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 75mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

TIROSINT-SOL Levothyroxine Solution 62.5mcg (IBSA) – Subpotent (2023)

Subpotent Drug

Class IIModerate

FDAJan 30, 2023Nationwide• IBSA PHARMA INC

1...97 9899100 101...719

Page 99 of 719Next